What is Aurinia Pharmaceuticals's stock issuance proceeds?

Aurinia Pharmaceuticals (AUPH) reported stock issuance proceeds of $713K in Q1 2026.

How has Aurinia Pharmaceuticals's stock issuance proceeds changed year-over-year?

Aurinia Pharmaceuticals's stock issuance proceeds decreased by 92.3% year-over-year, from $9.29M to $713K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Aurinia Pharmaceuticals AUPH Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Vera TherapeuticsVERA

$3.94M+157%

Agios PharmaceuticalsAGIO

$2.08M+28.4%

BridgeBio PharmaBBIO

$22.59M—

Kiniksa Pharmaceuticals International, plcKNSA

$6.39M+101%

Alumis Inc.ALMS

$323.8M+264,765%

Apogee Therapeutics, Inc.APGE

$378.17M—

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's stock issuance proceeds?: Aurinia Pharmaceuticals (AUPH) reported stock issuance proceeds of $713K in Q1 2026.
How has Aurinia Pharmaceuticals's stock issuance proceeds changed year-over-year?: Aurinia Pharmaceuticals's stock issuance proceeds decreased by 92.3% year-over-year, from $9.29M to $713K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.